is tirzepatide still on the fda shortage list 🚨 Alert: No Longer FDA's Drug As of October 2, 2024, has announced that the Tirzepatide shortage has been resolved. This means that all doses of FDA Proposes Ban on Bulk

This side effect is often most noticeable when first starting treatment or after a dose increase, which is why most protocols begin at a lower dose and increase gradually over time

Discontinuation Impact: Dysesthesia "rarely led to discontinuation" according to company statements

And this is happening against geopolitical and post-COVID supply chain challenges generally within the pharma industry. However, Barry sees some hope in alleviating the problem in the manufacturing sector, as drugmakers are pouring money into boosting their capacity to make GLP-1s

Always disclose all current medications, supplements, and health conditions to the evaluating clinician before starting

Patients with high-response variants often see faster early loss, while others benefit from compound switching or dual-pathway therapy like GLP-Squared to unlock faster progress